|
Issue |
Title |
|
No 4 (2022) |
Manifestation of pathognomonic signs in modeling diabetes mellitus with streptozotocin in BALB/c mice |
Abstract
PDF (Rus)
|
A. V. Sorokina, A. K. Zhanataev, Z. V. Chayka, I. A. Miroshkina, A. A. Lisitsyn, A. D. Durnev |
|
No 4 (2022) |
Study of the interaction of the GSB-106 BDNF neurotrophin dipeptide mimetic with the TrkB tyrosine kinase receptor using surface plasmon resonance technology |
Abstract
PDF (Rus)
|
A. V. Tarasiuk, Y. V. Mezentsev, O. V. Gnedenko, P. Yu. Povarnina, A. S. Ivanov |
|
No 3 (2022) |
The usage of drugs with cerebrovascular activity in mice with reduced attention level |
Abstract
PDF (Rus)
|
N. A. Sukhorukova, R. M. Salimov, G. I. Kovalev |
|
No 4 (2021) |
The influence of Piracetam and Phenotropil on brain dopamine and serotonin metabolism in CD-1 mice sub-populations, diverging in attention sustainability |
Abstract
PDF (Rus)
|
N. A. Sukhorukova, V. S. Kudrin, V. B. Narkevich, G. I. Kovalev |
|
No 1 (2021) |
On the mechanism of the antiarrhythmic action of fabomotizole hydrochloride in alcoholic cardiomyopathy |
Abstract
PDF (Rus)
|
I. A. Miroshkina, L. M. Kozhevnikova, I. B. Tsorin, V. N. Stolyaruk, M. B. Vititnova, S. A. Kryzhanovskii, A. D. Durnev |
|
No 1 (2021) |
Study of the electrophysiological mechanisms of anticonvulsant action of the original levetiracetam analog the compound GIZH-290 |
Abstract
PDF (Rus)
|
T. A. Voronina, S. A. Litvinova, N. A. Gladysheva, А. A. Yakovleva |
|
No 1 (2020) |
The effects of cycloprolylglycine and its analogues on brain monoaminergic systems in BALB/c mice |
Abstract
PDF (Rus)
|
A. A. Abdullina, E. V. Vasileva, V. S. Kudrin, V. B Narkevich, T. A. Gudasheva, K. N. Kolyasnikova, G. I. Kovalev |
|
No 2 (2017) |
The study of electrophysiological mechanisms of the action compounds LMG-124 |
Abstract
PDF (Rus)
|
I. B. Tsorin, V. P. Zinchenko, I. Yu. Teplov, A. M. Kosenkov, Yu. I. Murinov, M. S. Yunusov, S. A. Kryzhanovskii |
|
1 - 8 of 8 Items |
|